Claro Advisors’s Boston Scientific BSX Stock Holding History

Claro Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,229	Closed	-$203K	–	536
2026 Q1	$203K	Sell	3,229 -619	-16%	-$49.5K	0.02%	489
2025 Q4	$367K	Buy	+3,848	New	+$377K	0.05%	281
2025 Q3	–	Sell	-2,147	Closed	-$231K	–	403
2025 Q2	$231K	Sell	2,147 -427	-17%	-$43.2K	0.04%	340
2025 Q1	$260K	Sell	2,574 -161	-6%	-$16.2K	0.03%	427
2024 Q4	$244K	Buy	+2,735	New	+$241K	0.03%	411
2024 Q3	–	Sell	-2,612	Closed	-$201K	–	516
2024 Q2	$201K	Buy	+2,612	New	+$191K	0.03%	410
2019 Q1	–	Sell	-359	Closed	-$14K	–	254
2018 Q4	$14K	Buy	+359	New	+$13K	0.01%	609

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Claro Advisors's BSX Position: Q2 2026 in Review

Claro Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,229 shares — an estimated $203K sold.

Claro Advisors first reported a position in BSX in Q4 2018 and held it in 7 quarters. The position peaked at $367K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Claro Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Claro Advisors sold 3,229 Boston Scientific shares in Q2 2026, an estimated $203K.
Claro Advisors first reported a position in Boston Scientific in Q4 2018 and held it in 7 quarters.
Claro Advisors's Boston Scientific position peaked at $367K in Q4 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Claro Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.